Clinical Trials Browser

sintilimab × Dermatologic × Clear all

NCT05572463 2022-11-18

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

Phase 1/2 Withdrawn

Melanoma, Neoplasms

NCT04296786 2020-03-05

Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study

Phase 2 Unknown

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous